Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. on November 22, 2013. The report addresses a notice received from The Nasdaq Stock Market LLC regarding the Company's failure to meet continued listing requirements.
Key Financial Metrics
The filing highlights specific equity figures derived from the Company's Form 10-Q for the quarter ended September 30, 2013:
- Stockholders' Equity: $1,550,000 (as of September 30, 2013).
- Nasdaq Minimum Equity Requirement: $2,500,000.
- Market Value of Listed Securities: The filing states the Company did not meet the compliance alternative requirement as of November 21, 2013, but does not provide a specific dollar value.
- Net Income: The filing states the Company did not meet the compliance alternative requirement for net income from continuing operations, but does not provide a specific dollar value.
The filing text does not provide clear values for revenue, cash flow, margins, or total debt.
Material Changes and Listing Status
The Company is currently non-compliant with Nasdaq Listing Rule 5550(b)(1) due to insufficient stockholders' equity. Additionally, the Company failed to meet the alternative compliance standards regarding market value of listed securities or net income from continuing operations. This status represents a material risk to the Company's ability to maintain its listing on the Nasdaq Capital Market.
Outlook, Risks, and Management Commentary
Compliance Plan and Timeline:
- Nasdaq has granted the Company 45 calendar days (until January 6, 2014) to submit a specific plan to regain compliance.
- If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from November 22, 2013, to evidence compliance.
- The Company intends to submit a plan on or prior to January 6, 2014.
Risks and Contingencies:
- There is no assurance the Company will regain compliance or that its plan will be accepted.
- If compliance is not regained within the allowed timeframes, Nasdaq will issue a Staff Delisting Determination.
- The Company may appeal a rejection of its plan to a Nasdaq Hearings Panel.
- Current trading of the Company's common stock is unaffected at this time.
Investor Verification Checklist
- Verify the Company's submission of a compliance plan by the January 6, 2014 deadline.
- Monitor Nasdaq's acceptance or rejection of the submitted plan.
- Review the Company's Form 10-Q (filed November 19, 2013) for detailed financial statements regarding the $1,550,000 equity balance.
- Watch for any subsequent announcements regarding a Staff Delisting Determination if the plan is rejected or compliance is not met.